NVAX

NVAX Operating Cash Flow (Statement)

-$39.50MTTM · USD

Period ending:

NVAX FY Cash from OperationsUSD
NVAX FY Cash from Operations1996-12-31: -$3.30M1997-12-31: -$4.20M1998-12-31: -$3.60M1999-12-31: -$3.70M2000-12-31: -$10.04M2001-12-31: -$4.57M2002-12-31: -$21.07M2003-12-31: -$17.55M2004-12-31: -$30.10M2005-12-31: -$5.81M2006-12-31: -$14.81M2007-12-31: -$26.74M2008-12-31: -$24.31M2009-12-31: -$32.83M2010-12-31: -$32.85M2011-12-31: -$23.63M2012-12-31: -$18.23M2013-12-31: -$45.36M2014-12-31: -$67.01M2015-12-31: -$126.09M2016-12-31: -$255.47M2017-12-31: -$138.70M2018-12-31: -$184.83M2019-12-31: -$136.62M2020-12-31: -$42.54M2021-12-31: $322.95M2022-12-31: -$415.94M2023-12-31: -$713.97M2024-12-31: -$87.26M2025-12-31: -$244.64M$322.95M-$713.97M
1996-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

NVAX operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 30 observations from Dec 31, 1996 to Dec 31, 2025.

Novavax Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-244,635,000
-87,263,000
-713,967,000
-415,937,000
322,946,000
-42,541,000
-136,623,000
-184,825,000
-138,696,000
-255,467,000
-126,090,000
-67,014,000
-45,359,000
-18,229,000
-23,629,000
-32,852,000
-32,830,000
-24,310,000
-26,742,000
-14,810,000
-5,809,000
-30,099,000
-17,547,000
-21,066,000
-4,566,000
-10,044,000
-3,700,000
-3,600,000
-4,200,000
-3,300,000

Compare operating cash flow (statement)

All NVAX financial metrics · NVAX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.